# Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery

> **NCT01505231** · PHASE3 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 300 (estimated)

## Conditions studied

- Shock

## Interventions

- **DRUG:** Vasopressin
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT01505231
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2013-02
- **Final completion:** 2013-05
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01505231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01505231, "Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01505231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*